Item 7.01 Regulation FD Disclosure.

On February 15, 2022, Applied Therapeutics, Inc. released a presentation that contains company information to be used by members of management from time to time in a series of meetings with analysts, investors and other third parties. The presentation is attached to this Current Report on Form 8-K as Exhibit 99.1 and is incorporated herein by reference.

The information included in this Current Report on Form 8-K, including Exhibit 99.1 incorporated by reference herein, shall not be deemed "filed" for purposes of Section 18 of the Securities and Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that Section, or incorporated by reference into any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such filing.

Item 9.01 Financial Statements and Exhibits.





(d) Exhibit:

The following exhibit is attached with this current report on Form 8-K:





    Exhibit
      No.                                   Description
  99.1               February 2022 Corporate Overview Presentation
104                Cover Page Interactive Data File (embedded within the Inline
                   XBRL document)




  2

© Edgar Online, source Glimpses